Literature DB >> 12881473

Do studies with ACE N- and C-domain-selective inhibitors provide evidence for a non-ACE, non-chymase angiotensin II-forming pathway?

Ahsan Husain, Ming Li, Robert M Graham.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12881473     DOI: 10.1161/01.RES.0000084993.90444.6C

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


× No keyword cloud information.
  4 in total

Review 1.  Early imaging in heart failure: exploring novel molecular targets.

Authors:  Jamshid Shirani; Jagat Narula; William C Eckelman; Navneet Narula; Vasken Dilsizian
Journal:  J Nucl Cardiol       Date:  2007-01       Impact factor: 5.952

2.  Role of ACE I/D gene polymorphisms on the effect of ramipril in inflammatory response and myocardial injury in patients undergoing coronary artery bypass grafts.

Authors:  Meral Urhan Küçük; Nehir Sucu; Seyhan Şahan Firat; Barlas Naim Aytaçoğlu; Özden Vezir; Caner Bozali; Necmiye Canacankatan; Seval Kul; Bahar Tunçtan
Journal:  Eur J Clin Pharmacol       Date:  2014-09-27       Impact factor: 2.953

Review 3.  Renin angiotensin aldosterone inhibition in the treatment of cardiovascular disease.

Authors:  Carlos M Ferrario; Adam E Mullick
Journal:  Pharmacol Res       Date:  2017-05-29       Impact factor: 7.658

Review 4.  Inhibition of RAAS--when is it too much?

Authors:  Pablo Navarro; Robert Moskowitz; Thierry H Le Jemtel
Journal:  Curr Heart Fail Rep       Date:  2004-07
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.